Exactech Ankle Recall Lawsuit: Broadspire Claims and TPG Suit

If you received a Vantage Total Ankle System implant from Exactech, you can file a lawsuit over the recalled polyethylene liner, but as of mid-2026 the Exactech ankle recall lawsuit process has produced no trials and no patient compensation. Exactech filed for Chapter 11 bankruptcy on October 29, 2024, which froze more than 2,500 pending federal and state cases. The center of the fight has shifted to a $1 billion fraud suit against TPG Capital, the private equity firm that owned Exactech, and that case will largely determine whether injured patients ever see meaningful recovery.

Which Ankle Devices Were Recalled and Why

The recall covers the polyethylene liner components of the Vantage Total Ankle System, Exactech’s only ankle replacement product line. Two versions are affected:¹

Vantage Fixed-Bearing Polyethylene Liner — 2,959 units distributed globally between 2004 and February 2022, item numbers 350-21-XX and 350-22-XX.
Vantage Mobile-Bearing Polyethylene Liner — 761 units distributed in the same window, item numbers 350-41-XX and 350-42-XX.

The defect was in the packaging, not the implant design. Exactech’s vacuum-sealed bags were missing a required oxygen barrier layer. Oxygen seeped in during shelf storage and oxidized the ultra-high molecular weight polyethylene, making the plastic brittle before a surgeon ever opened the package.²

Once implanted, the degraded liner wears down faster than expected. The debris triggers an immune response called osteolysis that eats away the bone anchoring the implant, causing loosening, instability, and often outright failure. The FDA estimated that roughly 80% of the knee and ankle devices Exactech manufactured over the roughly 18-year period from 2004 to 2021 were packaged in the flawed bags.²

The FDA classified the initial recall as Class II on October 4, 2021. Exactech expanded it on February 7, 2022, and sent an updated correction notice to surgeons and hospitals on April 7, 2022.²

Symptoms and Complications That Support a Claim

Patients with recalled Exactech devices have reported new or worsening pain around the joint, swelling, instability, grinding or clicking noises, and difficulty bearing weight. Medically, the degraded polyethylene has been linked to osteolysis, bone fracture, component loosening, and implant failure. The most consequential outcome for many patients is revision surgery, which is typically more complex, more painful, and less successful than the original operation.²

The FDA has advised patients who have a recalled Exactech device but no symptoms to continue routine monitoring with their surgeon rather than undergo preemptive surgery to remove a well-functioning implant.²

Where the Lawsuits Stand Now

On October 7, 2022, the Judicial Panel on Multidistrict Litigation consolidated Exactech product liability cases into In re: Exactech Polyethylene Orthopedic Products Liability Litigation, MDL No. 3044, before Judge Nicholas G. Garaufis in the U.S. District Court for the Eastern District of New York.³ By March 2026, the MDL had grown to 1,838 pending lawsuits, with more than 700 additional cases consolidated in Alachua County Circuit Court in Florida under Judge Donna M. Keim.⁴

Plaintiffs allege manufacturing and packaging defects, failure to warn surgeons and patients about polyethylene degradation, and fraudulent concealment. Whistleblower filings alleged Exactech knew of elevated failure rates in certain knee devices years before the recalls, and reporting by KFF Health News found the company delayed reporting roughly 400 adverse events to the FDA by two or more years past the required 30-day window.⁵

The MDL court had selected four bellwether cases with jury selection originally scheduled for mid-2025.⁴ None have taken place. Exactech’s Chapter 11 filing on October 29, 2024, in the U.S. Bankruptcy Court for the District of Delaware (Case No. 24-12441, Judge Laurie Selber Silverstein) triggered an automatic stay that froze all pending litigation and shelved the bellwether calendar.⁶

What You Can Recover Today Through Broadspire

The only compensation channel currently open to ankle-implant patients is a limited reimbursement program administered by a third-party claims company called Broadspire, hired by Exactech. It covers certain out-of-pocket expenses: mileage to medical appointments, insurance co-payments, deductibles, and medical supplies.⁵

What it does not cover is most of what a lawsuit would seek: pain and suffering, future medical care, and the cost of a replacement implant. The program is described as discretionary, meaning reimbursement decisions can change, and Broadspire acts as Exactech’s agent, so any information a patient submits may be shared with the company. Anyone considering both the reimbursement program and litigation should weigh that carefully with an attorney.⁵

Why the TPG Lawsuit Matters for Ankle Patients

A revised Chapter 11 plan confirmed by Judge Silverstein on September 17, 2025, and effective October 31, 2025, rejected a proposed $8.1 million release of TPG Capital and instead preserved claims against the firm. The plan created a litigation trust funded with $2 million to pursue those claims on behalf of unsecured creditors, which includes injured patients. Judge Silverstein noted it was the first time she had confirmed a bankruptcy plan that does not specify how personal injury claimants will ultimately be compensated.⁷

On February 5, 2026, the Exactech Settlement Trust, led by Trustee Ellen K. Reisman, sued TPG, Inc. and more than a dozen affiliates and principals in the Delaware Court of Chancery (Case No. 2026-0129-MTZ), seeking at least $1 billion.⁸

The 11-count complaint alleges that after TPG acquired Exactech for approximately $737 million in February 2018, it installed its senior advisor Jeffrey Binder as executive chairman and CEO, filled the board with TPG partners, and then ignored red flags about the defective implants, concealed the defects from regulators and surgeons, resisted recall demands, and delayed adverse event reporting to protect the value of its investment. When liabilities mounted, the Trust alleges, TPG pushed Exactech into bankruptcy and tried to shield itself with a low-ball settlement offer.⁹

The core legal theory is alter ego and veil piercing: that TPG dominated Exactech so completely that the two were functionally one company, making TPG directly liable for the product claims. TPG had earlier gotten similar veil-piercing claims dismissed in the MDL in 2023, but the bankruptcy judge ruled that Exactech and TPG “are and always have been adverse” on those claims, letting the Trust pursue them independently.⁹

The Chancery case was in its early stages as of early 2026. Whether ankle patients receive meaningful compensation for revision surgery, lost function, and pain and suffering depends largely on how that case resolves.

What to Do if You Have a Recalled Ankle Implant

Check your surgical records or ask your surgeon whether your ankle implant is a Vantage Fixed-Bearing or Mobile-Bearing polyethylene liner, and whether the item number falls within the recalled ranges. If you have symptoms — pain, swelling, instability, grinding, or difficulty bearing weight — see your orthopedic surgeon. If you have no symptoms, the FDA recommends routine monitoring rather than preemptive surgery.²

Because the litigation is stayed by bankruptcy and the outcome of the TPG case is unsettled, a product liability attorney familiar with the MDL can explain how filing now preserves your rights, how the litigation trust process works, and whether accepting Broadspire reimbursement fits your situation.

1
Exactech, Inc. Recall Information
2
U.S. Food and Drug Administration. Risks of Exactech Joint Replacement Devices Defective Packaging FDA Safety Communication
3
GovInfo. In Re: Exactech Polyethylene Orthopedic Products Liability Litigation, Transfer Order
4
Drugwatch. Exactech Replacement Lawsuits
5
KFF Health News. Exactech Knee Replacement Lawsuits Settlement
6
Kroll Restructuring. Exactech Inc. Restructuring
7
Brown Rudnick. Brown Rudnick on Behalf of UCC of Exactech Secures Approval for Revised Chapter 11 Plan Allowing Claims Against TPG to Proceed
8
Bloomberg Law. TPG Hit With $1 Billion Fraud Lawsuit Over Exactech Bankruptcy
9
Nigh Goldenberg Raso & Vaughn. Exactech Settlement Trust v. TPG Inc., Verified Complaint